Genetic and Epigenetic Background of Inner Ear Dysfunction in Turner Syndrome

NCT ID: NCT06507007

Last Updated: 2026-01-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-02-01

Study Completion Date

2027-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this case-control study is to pave the way for new revolutionary treatment measures within hearing loss that could either replace or delay the need for hearing aids. The study focuses on people with Turner syndrome (TS).

The aim is to find out if there are specific DNA methylation patterns and/or RNA expression profiles linked to sensorineural hearing loss (SNHL) in people with TS. Additionally, the structure and function of the inner ear in these individuals will be examined to see if there is a connection to their epigenetic profile.

The main question it aims to answer is: Does epigenetics constitute a common denominator for some of the unexplained SNHL cases?

Turner Syndrome (TS) represents an ideal model for studying epigenetics related to sensorineural hearing loss (SNHL).

Participants will undergo the following tests:

* Ear examinations
* Hearing tests
* Balance tests
* Blood tests
* MRI scans
* CBCT (cone-beam computed tomography) scans

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sensorineural Hearing Loss Turner Syndrome Inner Ear Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1

Individuals with TS and SNHL

No interventions assigned to this group

Group 2

Individuals with TS without SNHL

No interventions assigned to this group

Group 3

Healthy age matched controls without TS and without SNHL

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age between 18 and 60 years old

Exclusion Criteria

* Contraindications for the MRI or CBCT
* Serious medical disorders
* Neurological or psychiatric disorders of any kind
* Use of medication that is known to influence inner ear function
* Medical history with dizziness or hearing problems (controls only)
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Aarhus

OTHER

Sponsor Role collaborator

Aarhus University Hospital

OTHER

Sponsor Role collaborator

Gødstrup Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Louise Hill-Madsen

Medical Doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Therese Ovesen, Prof

Role: PRINCIPAL_INVESTIGATOR

University Clinic of Flavour, Balance and Sleep

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

ENT department of Gødstrup Hospital

Herning, , Denmark

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Louise Hill-Madsen, MD

Role: CONTACT

20282635 ext. 0045

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Louise Hill-Madsen, MD, PhD student

Role: primary

(45+) 78439744

Therese Ovesen, Professor

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LHM-TS-2024

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Genetics of Middle Ear Disease
NCT00422136 COMPLETED
Genetic Study of Age Related Hearing Loss
NCT01732289 COMPLETED EARLY_PHASE1
Study of Gene Associations and Infertility
NCT01223092 ENROLLING_BY_INVITATION
Dent Disease Mutation Genotyping
NCT01783795 COMPLETED NA
Tissue Sample Study for Mitochondrial Disorders
NCT01803906 ENROLLING_BY_INVITATION